(699.6) Long Noncoding RNAs Hepatocyte Nuclear Factor 4A Antisense RNA 1 and Hepatocyte Nuclear Factor 1A Antisense RNA 1 are Involved in Ritonavir-induced Cytotoxicity in Hepatoma Cells

Poster Board Number: B119

Xiaofei Wang (Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University), Yihang Yu (Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University), Pei Wang (Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University), Kun Yang (Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University), Mengyao Yan (Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University), Yiting Wang (Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University), Liang Yan (Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University), Xiao-bo Zhong (Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut), Lirong Zhang (Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University)

Ritonavir (RTV), a pharmacoenhancer used in anti-HIV regimens, can induce liver damage. RTV is mainly metabolized by cytochrome P450 3A4 (CYP3A4) in the liver. HNF4A antisense RNA 1 (HNF4A-AS1) and HNF1A antisense RNA 1 (HNF1A-AS1) are long noncoding RNAs (lncRNAs) that regulate the expression of pregnane X receptor (PXR) and CYP3A4. This study investigated the role and molecular mechanisms of HNF4A-AS1 and HNF1A-AS1 in RTV-induced hepatotoxicity. Small hairpin RNAs were used to knock down HNF4A-AS1 and HNF1A-AS1 in Huh7 and HepG2 cells. Lactate dehydrogenase and reactive oxygen species assays were performed to assess RTV-induced hepatotoxicity. Chromatin immunoprecipitation qPCR was used to detect PXR enrichment and histone modifications in the CYP3A4 promoter. HNF4A-AS1 knockdown increased PXR and CYP3A4 expression and exacerbated RTV-induced cytotoxicity, whereas HNF1A-AS1 knockdown generated the opposite phenotype. Mechanistically, enrichment of PXR and trimethylation of histone 3 lysine 4 (H3K4me3) in the CYP3A4 promoter was increased, and trimethylation of histone 3 lysine 27 (H3K27me3) was decreased after HNF4A-AS1 knockdown. However, PXR and H3K4me3 enrichment decreased after HNF1A-AS1 knockdown. Alterations in RTV-induced hepatotoxicity caused by decreasing HNF4A-AS1 or HNF1A-AS1 were reversed by knockdown or overexpression of PXR. Increased susceptibility to RTV-induced liver injury caused by the PXR activator rifampicin was attenuated by HNF4A-AS1 overexpression or HNF1A-AS1 knockdown. Taken together, these results revealed that HNF4A-AS1 and HNF1A-AS1 modulated RTV-induced hepatotoxicity by regulating CYP3A4 expression, primarily by affecting the binding of PXR and histone modification status in the CYP3A4 promoter.

This work was supported by the National Natural Science Foundation of China [Grants 82073931, 81773815].